1 |
Lornoxicam, Drugs Fut., 17(8), 683-686 (1992)
DOI
|
2 |
S.I. Ankier, A.E. Brimelow, P. Crome, A. Johnston, S.J. Warrington, P. Turner, H.P. Ferber, Chlortenoxicam pharmacokinetics in young and elderly human volunteers, Postgrad. Med. J., 64(756), 752-754 (1988)
DOI
ScienceOn
|
3 |
K.T. Olkkola, A.V. Brunetto, M.J. Mattila, Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents, Clin. Pharmacokinet., 26(2), 107-120 (1994)
DOI
ScienceOn
|
4 |
식품의약청안전청 고시 제 2002-60호, 생물학적동등성시험기준 (2002. 11. 22)
|
5 |
식품의약청안전청 고시 제 1999-67호, 의약품임상시험관리기준 (2000. 1. 4)
|
6 |
T. Suwa, H. Urano, Y. Shinohara, J. Kokatsu, Simultaneous high-performance liquid chromatographic determination of lornoxicam and its 5'-hydroxy metabolite in human plasma using electrochemical detection, J. Chromatography, 617(1), 105-110(1993)
DOI
ScienceOn
|
7 |
Statistical Solutions Ltd., Equiv 2.0, U.K. (2001)
|
8 |
S. Radhofer-Welte, P. Dittrich, Determination of the novel non-steroidal anti-inflammatory drug lornoxicam and its main metabolite in plasma and synovial fluid, J. Chromatography B, 707, 151-159 (1998)
DOI
ScienceOn
|
9 |
Neil M. Skjodt, Neal M. Davies, Clinical pharmacokinetics of lornoxicam, Clin. Pharmacokinet., 34(6), 421-428 (1998)
DOI
ScienceOn
|